Skip to main content

Table 1 Baseline demographic and disease features characteristics

From: Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis

Variables MELD < 30 MELD ≥ 30
WG (n = 323) HG (n = 323) P WG (n = 88) HG (n = 35) P
AgeDonor (years) 36.06 ± 11.95 36.3 ± 10.41 0.790 37.26 ± 15.75 37.66 ± 13.74 0.889
BMI Donor (kg/m2) 22.52 ± 2.24 22.78 ± 2.51 0.166 23.09 ± 2.33 22.73 ± 2.28 0.431
Age (years) 44.34 ± 10.15 43.76 ± 9.55 0.451 43.4 ± 10.88 44.55 ± 10.14 0.581
BMI (kg/m2) 22.41 ± 3.35 22.38 ± 3.1 0.923 22.76 ± 3.38 22.51 ± 2.79 0.677
Male (%) 265 (82%) 262 (81.1%) 0.761 30 (85.7%) 72 (81.8%) 0.604
CRE (μmoI/L) 72.54 ± 24.72 71.98 ± 24.33 0.774 140.78 ± 100.45 123.2 ± 100.83 0.384
ALB (g/L) 35.45 ± 6.61 35.04 ± 7.2 0.454 31.95 ± 4.77 32.32 ± 5.42 0.724
TB μmol/L 81.08 ± 125.71 73.22 ± 112.1 0.402 407.29 ± 219.85 406.91 ± 189.02 0.992
INR 1.35 ± 0.37 1.35 ± 0.37 0.960 3.11 ± 1.22 3.01 ± 1.1 0.646
PLT (109/L) 103.06 ± 82.96 96.59 ± 78.73 0.310 66.97 ± 44.95 67.05 ± 43.52 0.993
WBC (109/L) 5.65 ± 3.85 5.45 ± 3.41 0.486 9.3 ± 4.77 8.3 ± 4.95 0.309
HGB (g/L) 112.57 ± 27.68 112.12 ± 28.12 0.840 100.66 ± 24.02 98.77 ± 25.43 0.707
Tumor (%) 188 (58.2%) 185 (57.3%) 0.811 3 (8.6%) 8 (9.1%) 0.796
HBsAg positive (%) 231 (71.5%) 238 (73.7%) 0.537 27 (77.1%) 70 (79.5%) 0.768
Child–Pugh A (%) 68 (21.1%) 61 (18.9%) 0.491 0 0 NS
Child–Pugh B (%) 170 (52.6%) 168 (52%) 0.875 7 (20%) 10 (11.4%) 0.336
Child–Pugh C (%) 85 (26.3%) 94 (29.1%) 0.429 28 (80%) 78 (88.6%) 0.336
  1. BMI body mass index, CRE creatinine, ALB albumin, TB total bilirubin, INR International Normalized Ratio, MELD model end-stage liver disease, PLT platelet, WBC white blood cell, HGB hemoglobin, HBsAg hepatitis B surface antigen